Table 1 Clinical characteristics of the patients
Variables | HCs (n = 16) | CHB (n = 53) | LCs (n = 71) |
|---|---|---|---|
Female, n (%) | 10 (62) | 12 (23) | 18 (25) |
Male, n (%) | 6 (38) | 41 (77) | 53 (75) |
Age (years) | 33 (24.75,36) | 42 (34,54) | 51 (43,54.5) |
FIB-4 | 0.62 (0.44,0.76) | 1.16 (0.78,1.59) | 2.29 (1.50,3.70) |
APRI | 0.16 (0.16,0.19) | 0.31 (0.25,0.41) | 0.59 (0.44,0.95) |
LSM | NA | 7.7 (6.90,8.30) | 15 (12.60,19.05) |
PLT ((10^9 /L)) | 254.5 (237.25,277.75) | 199 (166,231) | 119 (80,148.50) |
AST (U/L) | 18.5 (15,20.25) | 24 (21,27) | 27 (24,34.50) |
ALT (U/L) | 17.5 (8,22.25) | 24 (16,44) | 26 (23,33.50) |
TBIL (umol/L) | 10.1 (6.82,12.40) | 12.8 (8.90,17.80) | 13.6 (9.80,17.40) |
ALB (g/L) | 48.8 (47.77,50.17) | 47.6 (45.70,49.80) | 46.8 (43.50,49.25) |
AFP | NA | 2.35 (1.71,3.31) | 2.54 (1.89,3.78) |
HBeAG (IU/ml) | NA | 0.65 (0.53,2.13) | 0.68 (0.41,1.93) |
HBSAG (IU/ml) | NA | 2006.08 (810.12,4304.03) | 1048.04 (389.50,1894.02) |
PTA (%) | 109 (99,114) | 107 (100,114) | 88 (79,99) |
INR | 0.94 (0.92,0.98) | 0.97 (0.93,1) | 1.08 (1,1.15) |
